Table 2.
Components | Traditional cigarettes | Electronic cigarettes |
---|---|---|
Major constituents | Nicotine | Nicotine |
Carbon monoxide | Propylene glycol | |
Nitrosamines | Glycerol | |
Aromatic hydrocarbons | Flavoring | |
Aldehydes | ||
>4,000 Chemical compounds | ||
Effects on inflammatory cells | Increase in inflammatory cytokines, such as IL-1 and TNF-alpha | No increase in WBC |
Increase number and reactivity of neutrophils in the blood stream | Decreased density and viability of Kupffer cells | |
Decrease in neutrophil and monocyte chemotaxis | Increase complement protein activation and deposition onto liver Kupffer cells | |
Decrease in neutrophil and macrophage migration into wounded issue | Enhanced C1q receptor expression on Kupffer cells | |
Decrease in neutrophil and macrophage oxidative burst and phagocytic activity, resulting in decreased ability to clear wounds of bacteria | Increase Kupffer cell cytokine release | |
Increase in proteolytic enzymes (specifically MMP-8 and MMP-9) leading to increased collagen degradation and weaker wound strength | Enhanced hydrogen peroxide production due to increased xanthine oxidase and peroxidase activity | |
ROS inhibit anti-proteases | Decreased epithelial cell, alveolar macrophage and neutrophil anti-microbial activity against staph aureus | |
Upregulation of certain inflammatory markers and acute phase reactants | ||
Some vapor extracts promote ROS formation | ||
Effects on cellular proliferation and wound healing process | Reduced fibroblast proliferation | Enhanced epithelial cell death with exposure to vapor extract |
Reduced pro-collagen (I and III) and collagen (I and III) synthesis | Decreased endothelial cell proliferation | |
Reduced hydroxyproline accumulation | Increased DNA strand breaks in epithelial and squamous cell lines exposed to e-cigarette vapor, with or without nicotine | |
Likely reduced endothelial angiogenesis | ||
Reduced epidermal regeneration with thinner epidermis and stratum corneum and reduced epidermal barrier | ||
Reduced levels of Vitamin C and E, with reduced ability to clear ROS and increased defective collagen synthesis | ||
ROS contribute to increased destruction of cell membranes, endothelial dysfunction and cellular apoptosis | ||
Effects on clotting cascade | Increase in platelet activation | Largely unknown |
Increase circulating fibronectin | ||
Overall increased propensity to form blood clots | ||
Effects on blood vessels | Oxidative stress on endothelial cells | Cytotoxic to endothelial cells, whether or not vapor contains nicotine |
Induces vasoconstriction | Morphologic alterations to endothelial cells, including disruptions to endothelial cell barrier and cell-to-cell contacts | |
Inhibits endothelial-dependent vasodilation | ||
Stimulates catecholamine release and adrenergic stimulation contributing to vasoconstriction | ||
Effects on tissue oxygenation | Vasoconstriction induces hypoxia | Reduced cutaneous blood flow |
Decreased subcutaneous blood flow | ||
Decreased tissue oxygen tension | ||
Increased lactate levels and anaerobic metabolism in tissue | ||
Carbon monoxide shifts oxygen dissocation curve to the left and has 200 times higher affinity for hemoglobin, decreasing oxygen delivery to peripheral tissues | ||
Cardiovascular effects | Accelerated atherosclerotic disease | Smokers switching to e-cigarettes with elevated systolic blood pressure at baseline demonstrate a decrease in systolic blood pressure after 1 year of smoking cessation with e-cigarette use |
Increased risk of CAD and MI | ||
Pulmonary effects | Increased risk of lung cancer | Increased dynamic airway resistance |
Increased risk of COPD and other lung disorders | Increased expired NO | |
Airway colonizer staph aureus demonstrates increased virulence, biofilm formation and enhanced invasion of host epithelial cells when exposed to vapor extract | ||
Associated surgical complications | SSI | Increased distal skin flap necrosis in rats |
Delayed wound healing | Largely unknown in humans | |
Wound dehiscence | ||
Incisional hernia | ||
Skin flap necrosis | ||
Tissue flap necrosis |
IL-1, interleukin 1; TNF-alpha, tumor necrosis factor-alpha; WBC, white blood cell; MMP, matrix metalloproteinase; ROS, reactive oxygen species; CAD, coronary artery disease; MI, myocardial infarction; COPD, chronic obstructive pulmonary disease; NO, nitric oxide; SSI, surgical site infection.